1.53 -0.10 (-5.95%)
XOMA
| Trade XOMA now with |
|
Stock Details
Last Trade:1.53 Change:-0.10 (-5.95%) Prev Close:1.63 Open: 1.68 Days Range:1.51 – 1.74 52 Week Range: 1.04 - 5.65 Volume:1014778 P/E: N/AEPS:-1.51
View AllRecent Alerts 02/07/12
Recent Alert on 01/23/12 at 8:48am
Canaccord Genuity Reiterates a 'Hold' on XOMA, Ltd. (XOMA); Strategy Shift a Move in Right Direction, but Awaiting More 052, Aceon Development Detail
Canaccord Genuity Reiterates a 'Hold' on XOMA, Ltd. (XOMA); Strategy Shift a Move in Right Direction, but Awaiting More 052, Aceon Development Detail
Canaccord Genuity reiterates a 'Hold' on XOMA, Ltd. (NASDAQ: XOMA) price target of $2.00. Analyst, Ritu Baral, said, "Reiterate rating and price target on XOMA on XOMA--052 (gevokizumab) potential in non--infectious uveitis and cardiovascular.... Read More
Recent Alert on 01/17/12 at 4:06pm
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
Recent Alert on 01/17/12 at 4:06pm
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
Recent Alert on 01/17/12 at 4:06pm
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
Recent Alert on 01/17/12 at 4:06pm
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
XOMA Corp. (XOMA) Acquires U.S. Perindopril Rihts from Les Laboratoires Servier
View AllRecent Press Releases
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 11/16/11 at 1:40am
XOMA's CEO Presents at the Eighth Annual Lazard Capital Markets Healthcare Conference - Conference Call Transcript
XOMA's CEO Presents at the Eighth Annual Lazard Capital Markets Healthcare Conference - Conference Call Transcript